Oncology Research and Treatment
Journal Abbreviation: Oncol Res Treat
ISSN: 2296-5270
eISSN: 2296-5262
Publisher: Karger Publishers
Publications (237)
Multiplex Tissue Analysis of the Tumor Microenvironment and Crucial Factors in Melanoma Pathogenesis (2020)
Ostalecki C, Lee JH, Schierer S, Collenburg L, Schuler G, Baur A
Conference contribution
Medication Safety in Patients Treated with New Oral Antitumor Agents: A Prospective, Randomized Investigation on the Impact of Intensified Clinical Pharmaceutical/Clinical Pharmacological Care on Patient Safety and Well-Being (AMBORA). Supported by the German Cancer Aid (70112447) within the Comprehensive Cancer Center Erlangen-EMN (2020)
Schlichtiq K, Duerr P, Fromm M, Dörje F
Conference contribution
IVOPAK II Study: Morbidity Following Secondary Resection of Colorectal Liver Metastases (2020)
Schellerer V, Merkel S, Grützmann R, Kersting S, Wein A
Conference contribution
The Intratumoral and Intestinal Microbiome in Pancreatic Cancer (2020)
Langheinrich M, Wirtz S, Grützmann R, Kersting S, Weber G
Conference contribution
Sarcopenia Assessments as Predictors of Overall Survival in Patients with Metastatic Renal Cell Carcinoma (2020)
Kuemmerl L, Lesyuk W, Goebell P, Kahlmeyer A
Conference contribution
Altered Diversity and Composition of the Microbiome in Patients with Primary Untreated Colorectal Cancer (2020)
Langheinrich M, Wirtz S, Weber K, Grützmann R, Kersting S
Conference contribution
Short and Long Term Outcome for Patients with Surgical Removal of Sacrococcygeal Teratoma in Newborns and Infancy (2020)
Ai M, Schellerer V, Besendörfer M
Conference contribution
Prognostic Significance of CD8-Based Immune Status Inflamed, Immune-Excluded and Immune Desert in Head and Neck Tumors can be Further Subdivided by Regulatory T Cells (2020)
Distel L, Echarti A, Fietkau R, Hecht M
Conference contribution
The Influence of Body Mass Index on Long-Term Prognosis in Patients with Colon Carcinomas (2020)
Merkel S, Fuchs J, Schellerer V, Brunner M, Geppert CI, Grützmann R, Weber K
Conference contribution
Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines (2020)
Jefremow A, Wiesmüller M, Rouse RA, Dietrich P, Kremer A, Waldner M, Neurath M, Siebler J
Conference contribution